Science News
from research organizations

New toxin may be key to MRSA severity

Date:
July 17, 2010
Source:
NIH/National Institute of Allergy and Infectious Diseases
Summary:
A research project to identify all the surface proteins of USA300 -- the most common community-associated strain of the methicillin-resistant form of the bacterium Staphylococcus aureus -- has resulted in the identification and isolation of a plentiful new toxin that laboratory studies indicate is a potent killer of human immune cells. Scientists say the toxin could be a key factor in the severity of MRSA infections in otherwise healthy people.
Share:
       
FULL STORY

A research project to identify all the surface proteins of USA300—the most common community-associated strain of the methicillin-resistant form of the bacterium Staphylococcus aureus (MRSA)—has resulted in the identification and isolation of a plentiful new toxin that laboratory studies indicate is a potent killer of human immune cells. Scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, say the toxin could be a key factor in the severity of MRSA infections in otherwise healthy people.

The toxin, named LukGH, consists of two small proteins found on the surface of the bacteria and is secreted freely into the surrounding environment.

The scientists identified 113 proteins associated with the surface of USA300 and began to examine the role of the previously uncharacterized proteins. S. aureus surface proteins are key indicators of how the pathogen will respond to contact with immune system cells, such as neutrophils, which the body produces in large numbers to kill invading microbes. Some proteins can aggressively attack these immune cells, and the demise of the neutrophils ultimately enables the bacteria to replicate and thrive. When the LukGH toxin was removed from USA300, studies showed that the strain caused little to no damage to human neutrophils. With the toxin present, the bacteria began forming pores in neutrophils which eventually led to their destruction.

The scientists, including Frank DeLeo, Ph.D., Chief of the Laboratory of Human Bacterial Pathogenesis, say they do not know the full contribution of LukGH to the severity of MRSA infection. However, LukGH is the only MRSA toxin currently known to promote destruction of human neutrophils after the bacteria have been ingested by the immune cells designed to destroy them.

Using animal models of MRSA infection, the NIH team is continuing to study the role of LukGH in disease.


Story Source:

The above post is reprinted from materials provided by NIH/National Institute of Allergy and Infectious Diseases. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ventura et al. Identification of a novel Staphylococcus aureus two-component leukotoxin using cell surface proteomics. PLoS ONE, 2010; 5 (7): e11634 DOI: 10.1371/journal.pone.0011634

Cite This Page:

NIH/National Institute of Allergy and Infectious Diseases. "New toxin may be key to MRSA severity." ScienceDaily. ScienceDaily, 17 July 2010. <www.sciencedaily.com/releases/2010/07/100716222228.htm>.
NIH/National Institute of Allergy and Infectious Diseases. (2010, July 17). New toxin may be key to MRSA severity. ScienceDaily. Retrieved September 5, 2015 from www.sciencedaily.com/releases/2010/07/100716222228.htm
NIH/National Institute of Allergy and Infectious Diseases. "New toxin may be key to MRSA severity." ScienceDaily. www.sciencedaily.com/releases/2010/07/100716222228.htm (accessed September 5, 2015).

Share This Page: